TelyRx Partners With Women’s Wellness Brand SISTERLY to Expand Menopause Support
Menopause Support is becoming a broader focus for digital healthcare provider TelyRx following its October 7, 2026, partnership with SISTERLY, an Irish, female-founded nutritional wellness brand. The collaboration will bring SISTERLY’s flagship supplement, The Elevator, to TelyRx’s U.S. pharmacy platform, expanding the options available to women experiencing perimenopause and menopause. The announcement was made during World Menopause Month and reflects growing interest in combining convenient healthcare access with nutritional products designed for women’s needs.
TelyRx operates a digital healthcare and pharmacy platform that connects patients with independent, licensed healthcare providers and facilitates prescription fulfillment through its pharmacy operations. SISTERLY focuses on nutritional supplements developed specifically for women. Through this partnership, TelyRx intends to offer its customers an additional non-prescription option alongside its existing prescription menopause treatments.
The collaboration also highlights the role of female leadership in the women’s healthcare market. Vanessa Slowey, president and CEO of TelyRx, has emphasized the importance of giving women more choices as they navigate menopause. Jennifer O’Connell, co-CEO and co-founder of SISTERLY, similarly described the partnership as an opportunity to make the brand’s product available to more women in the United States.
Menopause Support Expands Through a Digital Pharmacy Partnership
The partnership introduces The Elevator, a daily multivitamin formulated by SISTERLY with 23 nutrients in a powder sachet. According to the companies, the formula was developed with input from doctors, nutritionists, scientists and women’s health specialists. Its stated nutritional aims include supporting energy metabolism, normal immune function, normal hormonal activity and the maintenance of healthy skin, hair and nails.
TelyRx says it will become SISTERLY’s first U.S. pharmacy partner to offer the product. By adding a nutritional supplement to its existing women’s health offering, the company is broadening the types of products available through its platform.
The partnership reflects a wider shift in digital healthcare, where platforms are increasingly seeking to provide patients with more convenient ways to explore healthcare services and wellness products. For women experiencing midlife changes, access to relevant information and qualified healthcare professionals can be important when deciding how to address symptoms and nutritional needs.
However, supplements and prescription medicines serve different purposes. A multivitamin may help provide nutrients, but it should not be presented as a proven treatment for menopause symptoms or as a replacement for medical assessment. The suitability of any supplement depends on individual nutritional needs, existing health conditions and possible interactions with medications.
Menopause Support and the Role of Women’s Health Leadership
The announcement places female-founded SISTERLY and TelyRx’s leadership at the center of a commercial effort to expand women’s healthcare options. SISTERLY was founded by women who identified a need for nutritional products developed with greater attention to women’s physiology. Its approach involves working with healthcare and nutrition professionals during product development.
TelyRx CEO Vanessa Slowey has described the company’s strategy as an effort to provide women with a wider range of choices. The company’s existing digital pharmacy model connects patients with independent healthcare providers who evaluate medical needs and determine whether prescription treatment is appropriate.
Jennifer O’Connell, SISTERLY’s co-CEO and co-founder, said the partnership would help bring The Elevator to more women in the U.S. through a platform already expanding its menopause offering. The agreement therefore combines SISTERLY’s nutritional product with TelyRx’s digital distribution and pharmacy infrastructure.
The collaboration does not establish that the supplement is effective for every menopause-related concern. Its potential value should be evaluated according to its ingredients, nutritional evidence, safety information and the needs of individual users. Women experiencing persistent or severe symptoms should consult qualified healthcare professionals about appropriate assessment and treatment options.
The partnership also illustrates how companies can use distribution agreements to reach new customers without developing an entirely new product portfolio internally. For SISTERLY, access to TelyRx’s platform offers an additional route into the U.S. market. For TelyRx, the arrangement expands its women’s wellness offering beyond prescription treatments.
Menopause Support Requires Evidence-Based Healthcare Choices
Perimenopause and menopause can involve changes in menstrual patterns, sleep, mood, body temperature and other aspects of physical well-being. Experiences vary considerably, and some symptoms may have causes unrelated to hormonal changes. Access to reliable information and individualized medical advice remains important when deciding which options are appropriate.
Nutritional products can play a role in addressing specific dietary needs, but their benefits depend on formulation, dosage, individual circumstances and the evidence supporting particular claims. Consumers should review ingredient lists and consult healthcare professionals when they have medical conditions, take prescription medicines or are unsure whether a supplement is suitable for them.
The TelyRx–SISTERLY partnership offers an example of how digital pharmacy platforms are expanding into adjacent areas of women’s wellness. The commercial development may increase product availability, but it should not be confused with a new clinical breakthrough or proof that a nutritional formula treats menopause.
For healthcare companies, the challenge is to communicate product benefits responsibly while helping customers understand the distinction between general nutritional support and medical treatment. Clear labeling, appropriate clinical guidance and transparent information about evidence are important parts of that process.
As the women’s healthcare market develops, partnerships between digital providers and female-founded wellness companies may create additional distribution opportunities. Their long-term value will depend on product quality, responsible marketing, customer access and whether offerings meet genuine consumer needs.
TelyRx’s partnership with SISTERLY represents a new addition to its women’s health portfolio. By making The Elevator available through its U.S. platform, the company is expanding the range of nutritional products offered alongside its existing services. For women navigating midlife, the announcement underscores the importance of informed choices, reliable healthcare guidance and a clear understanding of what supplements can—and cannot—do.
